Delayed vitreous hemorrhage after placement of a ganciclovir implant for cytomegalovirus retinitis.
OBJECTIVE
To report a massive vitreous hemorrhage in a 26-year-old woman that occurred approximately 6 weeks after she received a ganciclovir implant.


METHODS
Case report.


RESULTS
The cytomegalovirus retinitis was inactivated after uncomplicated insertion of a ganciclovir implant. Approximately 6 weeks later, the patient was examined for sudden painless visual loss caused by a dense vitreous hemorrhage.


CONCLUSIONS
Sustained-release ganciclovir implants may be associated with delayed vitreous hemorrhage.
Virata
S R
SR
Department of Ophthalmology, University of North Carolina School of Medicine, Chapel Hill, USA.
Kylstra
J A
JA
D000328:Adult; D003586:Cytomegalovirus Infections / Q000188:drug therapy*; D004343:Drug Implants / Q000009:adverse effects*; D005260:Female; D015774:Ganciclovir / Q000009:adverse effects*; D006801:Humans; D012173:Retinitis / Q000821:virology*; D013997:Time Factors; D014823:Vitreous Hemorrhage / Q000209:etiology*
D004343:Drug Implants; D015774:Ganciclovir